Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
261
NCT01406587
Safety and Efficacy of PP4001 for the Treatment of Symptoms Associated With Uncomplicated Urinary Tract Infection
Phase: Phase 2
Role: Lead Sponsor
Start: Jul 31, 2011
Completion: Oct 31, 2011